[go: up one dir, main page]

ES2187738T3 - Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen. - Google Patents

Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.

Info

Publication number
ES2187738T3
ES2187738T3 ES97402202T ES97402202T ES2187738T3 ES 2187738 T3 ES2187738 T3 ES 2187738T3 ES 97402202 T ES97402202 T ES 97402202T ES 97402202 T ES97402202 T ES 97402202T ES 2187738 T3 ES2187738 T3 ES 2187738T3
Authority
ES
Spain
Prior art keywords
flavonas
derivatives
contain
preparation procedure
pharmaceutical compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97402202T
Other languages
English (en)
Inventor
Alain Dhainaut
Guy Lewin
Emmanuel Canet
Michel Lonchampt
Yves Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of ES2187738T3 publication Critical patent/ES2187738T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

COMPUESTOS QUE RESPONDEN A LA FORMULA GENERAL (I): DONDE: NO, UN GRUPO ALQUIL; LMENTE SUSTITUIDO Y COMO DEFINIDO EN LA DESCRIPCION, UN GRUPO CICLOALQUIL O UN GRUPO POLICICLOALQUIL COMO DEFINIDOS EN LA DESCRIPCION; HIDROXI; EFINIDO EN LA DESCRIPCION, DE APLICACION EN TERAPEUTICA COMO INHIBIDORES DE PDE4.
ES97402202T 1996-09-27 1997-09-23 Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen. Expired - Lifetime ES2187738T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611808A FR2753969B1 (fr) 1996-09-27 1996-09-27 Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2187738T3 true ES2187738T3 (es) 2003-06-16

Family

ID=9496129

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97402202T Expired - Lifetime ES2187738T3 (es) 1996-09-27 1997-09-23 Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.

Country Status (18)

Country Link
US (1) US5889003A (es)
EP (1) EP0832886B1 (es)
JP (1) JPH10114766A (es)
CN (1) CN1094936C (es)
AT (1) ATE227712T1 (es)
AU (1) AU728990B2 (es)
BR (1) BR9704900A (es)
CA (1) CA2216617C (es)
DE (1) DE69717044T2 (es)
DK (1) DK0832886T3 (es)
ES (1) ES2187738T3 (es)
FR (1) FR2753969B1 (es)
HU (1) HUP9701588A3 (es)
NO (1) NO974455L (es)
NZ (1) NZ328858A (es)
PL (1) PL322297A1 (es)
PT (1) PT832886E (es)
ZA (1) ZA978652B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69634900T2 (de) * 1995-09-11 2006-05-18 Osteoarthritis Sciences, Inc., Cambridge Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
KR20010072931A (ko) 1998-08-26 2001-07-31 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 폐 질환 치료 요법
CA2345311A1 (en) * 1998-09-24 2000-03-30 Kazutoshi Watanabe Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
CZ302882B6 (cs) 1999-08-21 2012-01-04 Nycomed Gmbh Farmaceutický prostredek
US6806257B1 (en) 1999-10-20 2004-10-19 Board Of Trustees Of Southern Illinois University Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
US6334998B1 (en) 1999-12-07 2002-01-01 Parker Hughes Institute Estrogens for treating ALS
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
US6472436B1 (en) * 2000-07-17 2002-10-29 The Salk Institute For Biological Studies Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production
DE10104350A1 (de) 2001-02-01 2002-08-14 Merck Patent Gmbh Verfahren zur Herstellung von Flavon Derivaten
DE10232595A1 (de) * 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
BRPI0409229A (pt) 2003-04-01 2006-03-28 Applied Research Systems inibidores das fosfodiesterases na infertilidade
JP5058481B2 (ja) * 2005-11-28 2012-10-24 丸善製薬株式会社 角化細胞増殖剤、サイクリックａｍｐホスホジエステラーゼ阻害剤、及び保湿剤
JPWO2008026687A1 (ja) * 2006-09-01 2010-01-21 杏林製薬株式会社 ピラゾロピリジンカルボキサミド誘導体及びそれらを含有するホスホジエステラーゼ（ｐｄｅ）阻害剤
CN101148444A (zh) * 2006-09-20 2008-03-26 上海特化医药科技有限公司 黄酮衍生物、制备方法及应用
KR100930467B1 (ko) 2007-06-07 2009-12-08 동아제약주식회사 점액분비를 촉진시키는 3',4',5-트리메톡시 플라본 유도체화합물, 그의 제조방법 및 약학적 용도
JP4559531B1 (ja) * 2009-12-03 2010-10-06 ウシオケミックス株式会社 ノビレチンの製造方法
CN103059005B (zh) * 2012-11-22 2015-04-22 中南民族大学 白杨素酰胺衍生物及其医药用途
CN105906598B (zh) * 2016-05-19 2018-05-08 江苏耐雀生物工程技术有限公司 白杨素衍生物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623808B1 (fr) * 1987-12-01 1990-03-09 Adir Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2216617C (fr) 2002-12-03
DK0832886T3 (da) 2003-03-10
PT832886E (pt) 2003-03-31
FR2753969B1 (fr) 1998-10-30
ZA978652B (en) 1998-03-27
BR9704900A (pt) 1998-10-27
AU3927197A (en) 1998-04-02
DE69717044T2 (de) 2003-07-24
JPH10114766A (ja) 1998-05-06
NO974455L (no) 1998-03-30
NO974455D0 (no) 1997-09-26
DE69717044D1 (de) 2002-12-19
AU728990B2 (en) 2001-01-25
HU9701588D0 (en) 1997-11-28
NZ328858A (en) 1998-01-26
FR2753969A1 (fr) 1998-04-03
HUP9701588A2 (hu) 1998-12-28
ATE227712T1 (de) 2002-11-15
HUP9701588A3 (en) 1999-03-01
CN1094936C (zh) 2002-11-27
PL322297A1 (en) 1998-03-30
CA2216617A1 (fr) 1998-03-27
EP0832886B1 (fr) 2002-11-13
US5889003A (en) 1999-03-30
CN1179422A (zh) 1998-04-22
EP0832886A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
ES2187738T3 (es) Derivados de flavonas, su procedimiento de preparacion y los compuestos farmaceuticos que las contienen.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
MX9202619A (es) Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene.
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
MX9206503A (es) Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene.
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
MX9202289A (es) Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2196054T3 (es) Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos.
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
BR9811099A (pt) Inibidores de urocinase
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
MX9201295A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen.
MX9201653A (es) Derivados de benc imidazol ilo, procedimiento para su produccion y composiciones herbicidas que los contienen.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
MX9202300A (es) Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
MX9401080A (es) Compuestos heteroaromaticos.